Most clotting factors are made in the liver. Of the 13 clotting factors involved in blood coagulation, the liver synthesizes at least 11 of them — including fibrinogen (Factor I), prothrombin (Factor II), and Factors V, VII, IX, X, XI, XII, and XIII. A few factors originate elsewhere: von Willebrand factor is produced by endothelial cells lining blood vessels and megakaryocytes in bone marrow, while tissue factor (Factor III) is expressed by cells outside the bloodstream, particularly in the subendothelium. Calcium (Factor IV) isn’t a protein at all — it’s an ion absorbed through diet.
These factors work together in a tightly regulated sequence called the coagulation cascade to convert liquid blood into a stable clot at a wound site. When any factor is missing or dysfunctional — whether from liver disease, genetic conditions like hemophilia, or vitamin K deficiency — the result can range from mild bruising to life-threatening hemorrhage.
All 13 Clotting Factors: Where They’re Made and What They Do
Each clotting factor has a specific production site and a distinct role in coagulation. Here’s the complete breakdown:
| Factor | Name | Where It’s Made | Role in Coagulation | Vitamin K–Dependent? |
|---|---|---|---|---|
| I | Fibrinogen | Liver | Converted to fibrin to form the clot mesh | No |
| II | Prothrombin | Liver | Converted to thrombin, which activates fibrinogen | Yes |
| III | Tissue factor (thromboplastin) | Subendothelial cells, various tissues | Initiates the extrinsic pathway after tissue injury | No |
| IV | Calcium (Ca²⁺) | Dietary absorption (gut) | Required cofactor for multiple steps in both pathways | No |
| V | Proaccelerin (labile factor) | Liver, platelets | Cofactor in the prothrombinase complex | No |
| VII | Proconvertin | Liver | Activates the extrinsic pathway with tissue factor | Yes |
| VIII | Antihemophilic factor A | Liver (sinusoidal endothelial cells) | Cofactor to Factor IXa in the intrinsic pathway | No |
| IX | Christmas factor | Liver | Key enzyme in the intrinsic tenase complex | Yes |
| X | Stuart-Prower factor | Liver | Central enzyme in the common pathway | Yes |
| XI | Plasma thromboplastin antecedent | Liver | Activates Factor IX in the intrinsic pathway | No |
| XII | Hageman factor | Liver | Contact activation; initiates the intrinsic pathway | No |
| XIII | Fibrin-stabilizing factor | Liver, platelets, monocytes | Cross-links fibrin to stabilize the clot | No |
Note: Factor VI was originally described but later identified as activated Factor V, so it’s no longer recognized as a separate factor.
Why the Liver Is the Clotting Factor Factory
The liver’s role in coagulation is hard to overstate. Hepatocytes — the primary liver cells — produce the vast majority of circulating clotting factors and release them into the bloodstream as inactive precursors called zymogens. These zymogens remain dormant until vascular injury triggers their activation.
Four of these factors (II, VII, IX, and X) require vitamin K for their synthesis. Specifically, vitamin K acts as a cofactor for the enzyme gamma-glutamyl carboxylase, which adds carboxyl groups to glutamic acid residues on these proteins. Without this modification, the factors can’t bind calcium and are functionally useless. This is exactly why warfarin works as a blood thinner — it blocks vitamin K recycling, leaving these four factors inactive.
When liver function declines — as in cirrhosis, hepatitis, or acute liver failure — clotting factor production drops measurably. The PT/INR (prothrombin time/international normalized ratio) is one of the first lab values to become abnormal in liver disease because Factor VII has the shortest half-life of all clotting factors at roughly 4–6 hours.
How the Coagulation Cascade Actually Works
The traditional teaching divides coagulation into three pathways, though in reality they overlap significantly:
Extrinsic Pathway (Tissue Factor Pathway)
Tissue damage exposes tissue factor (Factor III) to blood. Tissue factor binds Factor VII, forming a complex that activates Factor X. This pathway is fast — it’s the body’s first response to a cut or wound. It’s measured clinically by the PT/INR.
Intrinsic Pathway (Contact Activation Pathway)
This pathway kicks in when blood contacts exposed subendothelial collagen or foreign surfaces. Factor XII activates, triggering a chain reaction through Factors XI → IX → X. It’s slower but amplifies the clotting response. The aPTT (activated partial thromboplastin time) measures this pathway.
Common Pathway
Both pathways converge at Factor X. Activated Factor X (Xa) combines with Factor V to form the prothrombinase complex, which converts prothrombin (II) to thrombin (IIa). Thrombin then converts fibrinogen (I) into fibrin strands. Factor XIII cross-links these fibrin strands into a stable, durable clot.
What Happens When Clotting Factors Fail
Deficiencies in specific clotting factors cause distinct bleeding disorders:
- Hemophilia A — Factor VIII deficiency. Affects ~1 in 5,000 males. Causes spontaneous joint and muscle bleeds in severe cases (Factor VIII levels below 1%).
- Hemophilia B (Christmas disease) — Factor IX deficiency. Affects ~1 in 25,000 males. Clinically identical to Hemophilia A.
- Von Willebrand disease — The most common inherited bleeding disorder, affecting up to 1% of the population. Von Willebrand factor helps platelets adhere to damaged vessels and carries Factor VIII.
- Vitamin K deficiency — Impairs Factors II, VII, IX, and X. Common in newborns (which is why vitamin K is given at birth) and in patients on prolonged antibiotics.
- Liver disease — Reduces production of nearly all clotting factors, causing a complex coagulopathy that’s difficult to manage.
- DIC (disseminated intravascular coagulation) — A dangerous condition where widespread clotting consumes clotting factors faster than the liver can replace them, paradoxically causing severe bleeding.
When to See a Doctor
Talk to your doctor if you experience any of the following, as these may indicate a clotting factor problem:
- Unexplained bruising or bruises that appear without injury
- Prolonged bleeding from minor cuts (lasting more than 10–15 minutes)
- Heavy or prolonged menstrual periods (menorrhagia)
- Nosebleeds that last longer than 20 minutes or recur frequently
- Blood in stool or urine without a clear cause
- Excessive bleeding after dental work or surgery
- Joint swelling or pain without trauma (may indicate bleeding into joints)
Initial workup typically includes a CBC, PT/INR, aPTT, and fibrinogen level. If these are abnormal, your doctor may order individual factor assays to pinpoint exactly which clotting factor is deficient.
Frequently Asked Questions
Which clotting factors are NOT made in the liver?
Tissue factor (Factor III) is made by subendothelial and extravascular cells. Calcium (Factor IV) comes from diet. Von Willebrand factor — while not one of the numbered 13 — is produced by endothelial cells and megakaryocytes. Factor VIII is also somewhat unique: current evidence suggests it’s primarily made by liver sinusoidal endothelial cells rather than hepatocytes, though it’s still liver-derived.
Which clotting factors need vitamin K?
Factors II, VII, IX, and X — sometimes remembered by the mnemonic “1972” (10, 9, 7, 2). Protein C and Protein S, which are natural anticoagulants, also require vitamin K. This is why warfarin, which blocks vitamin K, affects both clotting and anticoagulant pathways.
Can you have too many clotting factors?
Yes. Elevated levels of certain factors (especially Factor VIII, fibrinogen, and Factor XI) are associated with an increased risk of venous thromboembolism (DVT and pulmonary embolism). Factor V Leiden mutation doesn’t increase factor levels but makes Factor V resistant to inactivation, creating a hypercoagulable state affecting roughly 5% of Caucasians.
How does liver disease affect clotting?
Severe liver disease reduces production of both pro-coagulant factors (like II, V, VII, X) and anticoagulant proteins (like Protein C and antithrombin). The result is a fragile balance — patients can bleed excessively and form dangerous clots. An INR above 1.5 in liver disease is clinically significant and often signals advanced hepatic dysfunction.
What blood tests check clotting factor function?
The PT/INR evaluates the extrinsic and common pathways (Factors VII, X, V, II, and fibrinogen). The aPTT evaluates the intrinsic and common pathways (Factors XII, XI, IX, VIII, X, V, II, and fibrinogen). A thrombin time specifically tests fibrinogen-to-fibrin conversion. If screening tests are abnormal, specific factor assays can measure individual factor levels down to the percentage point.
